We are live on
!
Find out more
Adage Capital Partners Portfolio holdings
AUM
$64.8B
1-Year Est. Return
42.7%
This Fund
S&P 500
This Quarter
Est. Return
+6.93%
1 Year Est. Return
+42.7%
3 Year Est. Return
+139.29%
5 Year Est. Return
+204.38%
10 Year Est. Return
+829.83%
AUM
$36.3B
AUM Growth
-$345M
(-0.94%)
Cap. Flow
-$1.99B
Cap. Flow
% of AUM
-5.49%
Top 10 Holdings %
Top 10 Hldgs %
13%
Holding
771
New
91
Increased
196
Reduced
345
Closed
92
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CF Industries
CF
|
+$124M |
| 2 |
Merck
MRK
|
+$118M |
| 3 |
PNC Financial Services
PNC
|
+$109M |
| 4 |
STJ
St Jude Medical
STJ
|
+$108M |
| 5 |
Johnson Controls International
JCI
|
+$101M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$191M |
| 2 |
DD
Du Pont De Nemours E I
DD
|
+$184M |
| 3 |
American Airlines Group
AAL
|
+$181M |
| 4 |
MDVN
MEDIVATION, INC.
MDVN
|
+$170M |
| 5 |
EMC
EMC CORPORATION
EMC
|
+$152M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 16.24% |
| 2 | Technology | 11.85% |
| 3 | Financials | 11.02% |
| 4 | Consumer Discretionary | 10.01% |
| 5 | Industrials | 9.9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
476
Tempest Therapeutics
TPST
$14M
| $12.5M | 0.03% |
598
-9
| -1% | -$163K |
|
477
Xerox
XRX
$411M
| $12.5M | 0.03% |
468,986
-61,062
| -12% | -$1.58M |
|
|
SNI
478
DELISTED
Scripps Networks Interactive, Inc Common Class A
SNI
| $12.5M | 0.03% |
+197,162
| New | +$12.6M |
|
479
Acadia Healthcare
ACHC
$2.85B
| $12.4M | 0.03% |
250,000
| – | – |
|
480
Alliant Energy
LNT
$18.4B
| $12.4M | 0.03% |
+322,406
| New | +$12.6M |
|
481
CACI
CACI
$11.3B
| $12.2M | 0.03% |
121,029
+44,211
| +58% | +$4.26M |
|
482
CBRE Group
CBRE
$43B
| $12.2M | 0.03% |
436,100
+10,800
| +3% | +$308K |
|
483
Zions Bancorporation
ZION
$10.3B
| $12.1M | 0.03% |
391,600
+33,900
| +9% | +$963K |
|
484
F5
FFIV
$23.1B
| $12.1M | 0.03% |
97,400
-2,500
| -3% | -$304K |
|
485
Unum
UNM
$14.3B
| $12.1M | 0.03% |
341,869
-14,000
| -4% | -$474K |
|
|
AGRX
486
DELISTED
Agile Therapeutics
AGRX
| $11.9M | 0.03% |
850
| – | – |
|
487
Capri Holdings
CPRI
$1.88B
| $11.8M | 0.03% |
252,978
-41,839
| -14% | -$2.09M |
|
488
Alaska Air
ALK
$5.6B
| $11.8M | 0.03% |
179,400
-7,400
| -4% | -$487K |
|
489
Pinnacle West Capital
PNW
$12.2B
| $11.7M | 0.03% |
154,240
-6,600
| -4% | -$514K |
|
490
Toro Company
TTC
$9.06B
| $11.7M | 0.03% |
250,000
+149,294
| +148% | +$6.99M |
|
|
GNMX
491
DELISTED
Aevi Genomic Medicine Inc
GNMX
| $11.7M | 0.03% |
2,100,000
| – | – |
|
|
TIF
492
DELISTED
Tiffany & Co.
TIF
| $11.6M | 0.03% |
+159,990
| New | +$10.7M |
|
493
Icon
ICLR
$12.2B
| $11.6M | 0.03% |
150,000
-50,000
| -25% | -$3.76M |
|
|
SGMO
494
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
| $11.6M | 0.03% |
2,500,000
| – | – |
|
|
SCAI
495
DELISTED
Surgical Care Affiliates, Inc.
SCAI
| $11.6M | 0.03% |
237,183
+87,183
| +58% | +$4.02M |
|
496
Wynn Resorts
WYNN
$10.2B
| $11.6M | 0.03% |
118,700
+800
| +0.7% | +$78.1K |
|
497
Kohl's
KSS
$2.28B
| $11.5M | 0.03% |
+263,300
| New | +$11M |
|
|
CLCD
498
DELISTED
CoLucid Pharmaceuticals, Inc.
CLCD
| $11.4M | 0.03% |
+300,000
| New | +$4.43M |
|
499
Boise Cascade
BCC
$2.92B
| $11.4M | 0.03% |
450,000
-625,000
| -58% | -$16.1M |
|
|
PRAH
500
DELISTED
PRA Health Sciences, Inc.
PRAH
| $11.4M | 0.03% |
+202,100
| New | +$9.91M |
|
Similar funds
Adage Capital Partners's Q3 2016 Portfolio in Review
As of Q3 2016, Adage Capital Partners held 771 positions worth $36.3B, down 0.94% from $36.7B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
Adage Capital Partners withdrew a net $1.99B in Q3 2016, closing 92 positions and reducing 345 holdings. Its most notable exit was MEDIVATION, INC., an estimated $170M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 16% of assets, up from 15% a quarter earlier, followed by Technology and Financials.
Against the trend, Adage Capital Partners opened a new position in Kinder Morgan worth $64.8M.
- Adage Capital Partners's largest Q3 2016 buy was Kinder Morgan: 2,802,197 shares worth $64.8M.
- Adage Capital Partners added most to CF Industries in Q3 2016, an estimated $124M increase.
- Adage Capital Partners's biggest Q3 2016 reduction was Bristol-Myers Squibb, cutting an estimated $191M.
- Adage Capital Partners fully exited MEDIVATION, INC. in Q3 2016, selling an estimated $170M.
- Adage Capital Partners's ten largest holdings make up 13% of its $36.3B portfolio in Q3 2016.
- Adage Capital Partners opened 91 new positions and closed 92 in Q3 2016.
- Adage Capital Partners's portfolio value fell 0.94% quarter-over-quarter to $36.3B.
Based on Adage Capital Partners's 13F filing for Q3 2016, filed 14 Nov 2016.